PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients - Biognosys

PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients

Posters

Poster presented at ESMO 2022

 
Authors: Mitchell P. Levesque, Nigel Beaton, Kristina Beeler, Judy Kuo, Harry Nunns, Tobias Treiber, Julia Martinez Gomez, Jakob Vowinckel, and Anna Juncker-Jensen
Presenter: Mitchell P. Levesque (University of Zurich, Switzerland)

Date: September 10

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More